Enviar RFQ
EnglishEspañol
Enviar RFQ

Documento fuente o registro público

EP17 | Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures

The reference procedure for evaluating limit of blank, limit of detection and limit of quantitation.

Technical guidanceCLSISecond Edition; Date of Publication June 18, 2012; reaffirmed as of June 2017

Fuente

This document guides you through the evaluation and documentation of the detection capability of clinical laboratory measurement procedures, including limits of blank, detection, and quantitation.

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Key takeaways

The reference procedure for evaluating limit of blank, limit of detection and limit of quantitation.

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-10-09

Updated

2026-10-31

Disclaimer

professional use

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Solicitar cotización

Explorar más

Misma fuente

MM23 | Molecular Diagnostic Methods for Solid Tumors (Nonhematological Neoplasms)

The molecular-reference standard for solid-tumor testing, addressed to lab directors, developers and regulators.

Misma fuente

EP49 | Framework for Developing Evidence of Clinical Validity of Medical Laboratory Test Methods

CLSI’s framework for building evidence of clinical validity, written for manufacturers and for labs developing their own tests.

Mismo tipo de documento

Oncology Drug Products Used with Certain In Vitro Diagnostic Tests: Pilot Program

FDA source page describing its voluntary pilot program for selected oncology drugs used with in vitro diagnostic tests; participation and current status must be checked with FDA.